Oligomenorrhea in adolescent girls.
Forty-two patients ages 15 to 20 years (average 17.3 years) were evaluated for oligomenorrhea. Group I consisted of 19 patients with evidence of androgen excess (hirsutism, clitoromegaly, acne); and Group II included 23 patients without evidence of androgen excess. Sixteen of the 19 patients in Group I had elevated serum LH and normal FSH values. Serum total testosterone concentration was elevated in 12 patients and free T was elevated in one additional patient. In nine patients urinary 17KS excretion was elevated and dexamethasone suppressible. For the purpose of treatment, patients in Group I were divided into three subgroups: IA, polycystic ovary syndrome--12 patients; IB, adrenal block--two patients; IC, combined adrenal and ovarian hyperandrogenism--five patients. Among the 23 Group II patients, four had persistently elevated serum LH and normal FSH values, suggesting PCO; three had menopausal levels of LA and FSH; one had hyperprolactinemia and a depressed floor of the pituitary sella; and the remaining 15 patients had low to normal serum levels of LH and FSH, consistent with hypothalamic suppression. Guidelines for the diagnosis and treatment of adolescents with oligomenorrhea are discussed on the basis of these findings.
D015068:17-Ketosteroids / Q000652:urine; D000293:Adolescent; D000307:Adrenal Gland Diseases / Q000150:complications; D000328:Adult; D004700:Endocrine System Diseases / Q000097:blood / Q000652:urine; D005260:Female; D006065:Gonadotropins, Pituitary / Q000097:blood; D006801:Humans; D008599:Menstruation Disturbances / Q000209:etiology*; D009839:Oligomenorrhea / Q000097:blood / Q000209:etiology* / Q000652:urine; D011085:Polycystic Ovary Syndrome / Q000150:complications; D013739:Testosterone / Q000097:blood
D015068:17-Ketosteroids; D006065:Gonadotropins, Pituitary; D013739:Testosterone